Advances of Molecular Targeted Therapy in Squamous Cell Lung Cancer
Squamous cell lung cancer (SQCLC) is one of the most prevalent subtypes of lung cancer worldwide, about 400,000 persons die from squamous-cell lung cancer around the world, and its pathogenesis is closely linked with tobacco exposure. Unfortunately, squamous-cell lung cancer patients do not benefit...
Main Authors: | Li MA, Shucai ZHANG |
---|---|
Format: | Article |
Language: | zho |
Published: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2013-12-01
|
Series: | Chinese Journal of Lung Cancer |
Subjects: | |
Online Access: | http://dx.doi.org/10.3779/j.issn.1009-3419.2013.12.10 |
Similar Items
-
Research Status on Targeted Therapy for Squamous Cell Lung Cancer
by: Hong YUAN, et al.
Published: (2013-10-01) -
Research Progress of Targeted Therapy for Anaplastic Lymphoma Kinase and Other Rare Driver Genes in Advanced Non-small Cell Lung Cancer
by: Quan ZHANG, et al.
Published: (2017-01-01) -
Advances of Molecular Subtype and Targeted Therapy of Lung Cancer
by: Lan SHAO, et al.
Published: (2012-09-01) -
Landscape of targeted therapies for lung squamous cell carcinoma
by: Qiuxuan Chen, et al.
Published: (2024-10-01) -
Advances on Driver Oncogenes of Non-small Cell Lung Cancer
by: Jianguo ZHAO, et al.
Published: (2015-01-01)